| Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial 2003 · CA group · Adults aged 60–80 with mild to moderate Alzheimer-type dementia | 1.2 g | 180 days | 132 |
| Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial 2024 · αGPC group · Adults aged 55–85 with amnestic mild cognitive impairment | 600 mg | 12 weeks | 52 |
| Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial 2024 · DN group · Adults aged over 50 and under 85 with Alzheimer disease, MMSE score 26 or less, already taking donepezil stably for at least 3 months | 1.2 g | 24 weeks | 50 |
| Four-year follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder 2020 · choline group · Children aged 2.5–5.0 years at enrollment with prenatal alcohol exposure and fetal alcohol spectrum disorder | 513 mg | 274 days | 30 |
| Long-term follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder: corpus callosum white matter microstructure and neurocognitive outcomes 2022 · choline · Children aged 2.5–5 years with fetal alcohol spectrum disorder (FASD) | 513 mg | 39 weeks | 30 |
| Randomized, double-blind, placebo-controlled clinical trial of choline supplementation in school-aged children with fetal alcohol spectrum disorders 2016 · choline group · Children aged 5–10 years with fetal alcohol spectrum disorders and confirmed histories of heavy prenatal alcohol exposure | 625 mg | 6 weeks | 29 |
| Choline-Based Multi-Ingredient Supplementation Can Improve Explosive Strength during a Fatiguing Task 2021 · supplemental session · Male Division 2 college football players, age 20.4 ± 1.0 years, free from musculoskeletal disorders | 1.08 g | 1 day | 14 |
| Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study 2018 · 480 mg choline/d group · Women entering their third trimester of pregnancy | 480 mg | — | 13 |
| Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study 2018 · 930 mg choline/d group · Women entering their third trimester of pregnancy | 930 mg | — | 13 |
| Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance 2017 · 500 mg A-GPC · Healthy, recreationally trained college-aged men | 500 mg | 7 days | 12 |
| Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial 2022 · 930 mg/d group · Pregnant women aged 21 years or older in the third trimester, recruited at approximately 27 weeks gestation; generally healthy | 550 mg | 12 weeks | 11 |
| Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers 2015 · Low-dose CDP-choline · Healthy male volunteers; age not reported | 500 mg | 1 day | — |
| Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers 2015 · Moderate-dose CDP-choline · Healthy male volunteers; age not reported | 1 g | 1 day | — |
| Choline supplementation in children with fetal alcohol spectrum disorders: a randomized, double-blind, placebo-controlled trial 2015 · choline group · children aged 2.5–5 years with fetal alcohol spectrum disorders | 500 mg | 270 days | — |
| The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial 2017 · group A · patients with mild/moderate Alzheimer's disease; age and sex not stated | 1.2 g | 2 years | — |
| Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial 2025 · choline alfoscerate · Adults with type 2 diabetes and mild cognitive impairment, mean age 71.8 years; 69.4% women | 1.2 g | 1 year | — |
| Choline enhances elicited imitation memory performance in preschool children with prenatal alcohol exposure: a cumulative report of 3 randomized controlled trials 2025 · RCT1 and RCT2 choline groups · Children aged 2.5–5.9 years with fetal alcohol spectrum disorders | 500 mg | 274 days | — |
| Effect of rumen-protected choline and methionine on physiological and metabolic disorders and reproductive indices of dairy cows 2010 · rumen-protected choline (RPC) · Holstein dairy cows in their first or second lactation | 60 g | 24 weeks | — |
| Improved human visuomotor performance and pupil constriction after choline supplementation in a placebo-controlled double-blind study 2015 · Choline condition · Healthy right-handed students, mean age 19.5 years; 24 of the 28 participants were female, with no stated cardiac, hepatic, renal, neurological or psychiatric disorders | 2 g | 1 day | 28 |
| Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes 2021 · choline-treated arm · Pregnant women with heavy alcohol consumption, enrolled before 23 weeks’ gestation; their infants participated in the neonatal imaging study | 2 g | — | 28 |
| Effects of egg yolk choline intake on cognitive functions and plasma choline levels in healthy middle-aged and older Japanese: a randomized double-blinded placebo-controlled parallel-group study 2023 · Choline group · Japanese men and women aged 60–80 years without dementia who were concerned about, or had been told about, their forgetfulness | 300 mg | 12 weeks | 21 |
| Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance 2017 · 250 mg A-GPC · Healthy, recreationally trained college-aged men | 250 mg | 7 days | 12 |
| Comparison of the efficacy of inhaled budesonide and oral choline in patients with allergic rhinitis 2005 · Group B · Patients with allergic rhinitis; age and sex not reported | 1.5 g | 8 weeks | — |
| A placebo controlled trial of two dosages of LPC antagonist--choline in the management of bronchial asthma 1997 · Group B (low dose choline) · People with bronchial asthma; age and sex not reported | 1.5 g | 120 days | — |
| Effect of rumen-protected choline and methionine on physiological and metabolic disorders and reproductive indices of dairy cows 2010 · RPM + RPC · Holstein dairy cows in their first or second lactation | 60 g | 24 weeks | — |
| Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2018 · choline supplementation arm · Pregnant women aged 18 years or older with heavy prenatal alcohol exposure in Cape Town; infants were assessed as study outcomes. | 2.5 g | 130 days | 31 |
| Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial 2022 · 480 mg/d group · Pregnant women aged 21 years or older in the third trimester, recruited at approximately 27 weeks gestation; generally healthy | 100 mg | 12 weeks | 9 |
| Effects of rumen-protected methionine and choline supplementation on the preimplantation embryo in Holstein cows 2016 · CHO · Multiparous Holstein cows | 60 g | 51 days | 8 |
| Choline enhances elicited imitation memory performance in preschool children with prenatal alcohol exposure: a cumulative report of 3 randomized controlled trials 2025 · RCT3 choline group · Children aged 2.5–5.9 years with fetal alcohol spectrum disorders | 19 mg/kg | 274 days | — |
| A placebo controlled trial of two dosages of LPC antagonist--choline in the management of bronchial asthma 1997 · Group C (high dose choline) · People with bronchial asthma; age and sex not reported | 3 g | 120 days | — |
| A double-blind, randomized clinical trial of dietary supplementation on cognitive and immune functioning in healthy older adults 2014 · Ginkgo Synergy® plus Choline · Adults aged 60 years and older without cognitive impairment or specified major illnesses | 700 mg | 26 weeks | 33 |
| A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis 2017 · ch-OSA · Men and women aged 50–75 with symptomatic primary knee osteoarthritis | 200 mg | 12 weeks | 106 |
| Effects of rumen-protected methionine and choline supplementation on the preimplantation embryo in Holstein cows 2016 · MIX · Multiparous Holstein cows | 60 g | 51 days | 11 |
| The effect of choline-stabilized orthosilicic acid in patients with peri-implantitis: an exploratory randomized, double-blind, placebo controlled study 2021 · CS-OSA · Men and women aged 18–75 with peri-implantitis | 200 mg | 1 year | 10 |
| Dose and Timing of Prenatal Alcohol Exposure and Maternal Nutritional Supplements: Developmental Effects on 6-Month-Old Infants 2015 · MVM + choline group · Pregnant women, including moderate-to-heavy alcohol drinkers and low/unexposed comparison women; maternal age not specified | 750 mg | — | — |
| The impact of micronutrient supplementation in alcohol-exposed pregnancies on reaction time responses of preschoolers in Ukraine 2022 · MVM plus choline group · Pregnant women in Ukraine receiving MVM, including women with and without a history of prenatal alcohol exposure; children were followed into preschool age. | 750 mg | — | — |
| Plasma Kinetics of Choline and Choline Metabolites After A Single Dose of SuperbaBoost(TM) Krill Oil or Choline Bitartrate in Healthy Volunteers 2019 · Choline bitartrate · Healthy men and women, aged 18–65 years | 620 mg | 1 day | 12 |
| Differential metabolism of choline supplements in adult volunteers 2022 · Choline chloride · Healthy adult men aged 18 years or older | 740 mg | 1 day | 6 |
| Choline, an essential nutrient for humans 1991 · control (continued to receive choline) · Healthy male volunteers; age not reported | 500 mg | 5 weeks | — |
| Choline supplementation and measures of choline and betaine status: a randomised, controlled trial in postmenopausal women 2012 · choline supplementation · Healthy postmenopausal women | 1 g | 12 weeks | — |
| Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans 2012 · 480 mg choline/d, pregnant women · Healthy pregnant women, 27 weeks gestation | 480 mg | 12 weeks | — |
| Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans 2012 · 930 mg choline/d, pregnant women · Healthy pregnant women, 27 weeks gestation | 930 mg | 12 weeks | — |
| Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans 2012 · 480 mg choline/d, nonpregnant women · Healthy nonpregnant women | 480 mg | 12 weeks | — |
| Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans 2012 · 930 mg choline/d, nonpregnant women · Healthy nonpregnant women | 930 mg | 12 weeks | — |
| Choline intakes exceeding recommendations during human lactation improve breast milk choline content by increasing PEMT pathway metabolites 2015 · 930 mg choline/day · Women; lactating and control women were enrolled, but arm-specific population details are not reported. | 930 mg | 11 weeks | — |
| Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial 2016 · LYM-X-SORB (LXS), children aged 5.0–11.9 years · Children aged 5.0–11.9 years with cystic fibrosis and pancreatic insufficiency | 591 mg | 1 year | — |
| Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial 2016 · LYM-X-SORB (LXS), children aged 12.0–17.9 years · Children aged 12.0–17.9 years with cystic fibrosis and pancreatic insufficiency | 887 mg | 1 year | — |
| Maternal choline supplementation alters vitamin B-12 status in human and murine pregnancy 2019 · 480 mg choline/day group · Healthy third-trimester pregnant women | 480 mg | 12 weeks | — |
| Maternal choline supplementation alters vitamin B-12 status in human and murine pregnancy 2019 · 930 mg choline/day group · Healthy third-trimester pregnant women | 930 mg | 12 weeks | — |
| Benefits of Krill Oil Supplementation During Alternate-Day Fasting in Adults With Overweight and Obesity: A Randomized Trial 2025 · KO group · Healthy adults aged 25–65 with BMI >25 kg/m² and overweight or obesity; 25 women and 16 men enrolled | 156 mg | 12 weeks | 21 |
| Pregnancy induces transcriptional activation of the peripheral innate immune system and increases oxidative DNA damage among healthy third trimester pregnant women 2012 · Pregnant women, 930 mg/d choline intake · Healthy pregnant women aged 21 years or older, at 26–29 weeks’ gestation | 550 mg | 12 weeks | 13 |
| The Effects of Alpha-Glycerylphosphorylcholine on Heart Rate Variability and Hemodynamic Variables Following Sprint Interval Exercise in Overweight and Obese Women 2022 · A-GPC · Women aged 20–40 years with BMI >27 kg/m² who were overweight or obese, not regularly physically active, and without diagnosed chronic disease | 1 g | 1 day | 12 |
| Pregnancy induces transcriptional activation of the peripheral innate immune system and increases oxidative DNA damage among healthy third trimester pregnant women 2012 · Nonpregnant women, 930 mg/d choline intake · Healthy nonpregnant women aged 21 years or older | 550 mg | 12 weeks | 11 |
| Choline supplementation in children with fetal alcohol spectrum disorders has high feasibility and tolerability 2013 · choline group · Children aged 2.5–4.9 years with fetal alcohol spectrum disorders | 500 mg | 274 days | 10 |
| Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load 2005 · Baseline choline diet · Healthy men aged 20–46 years | 550 mg | 10 days | 8 |
| Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load 2005 · Choline repletion diet: 550 mg level · Men aged 20–46 years who had developed clinical choline depletion | 550 mg | 10 days | 4 |
| Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men 2010 · 550 mg/d group · Men aged 18–55 years with folate-compromised status | 550 mg | 12 weeks | — |
| Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men 2010 · 1100 mg/d group · Men aged 18–55 years with folate-compromised status | 1.1 g | 12 weeks | — |
| Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans 2012 · 930 mg/d choline group · Third-trimester pregnant women | 930 mg | 12 weeks | — |
| Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans 2012 · 480 mg/d choline group · Third-trimester pregnant women | 480 mg | 12 weeks | — |
| A higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1) 2013 · 480 mg choline/d · Healthy pregnant women at 26–29 weeks’ gestation | 480 mg | 12 weeks | — |
| A higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1) 2013 · 930 mg/d · Healthy pregnant women at 26–29 weeks’ gestation | 930 mg | 12 weeks | — |
| Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis 2016 · 480 mg/d choline group · pregnant, lactating, and nonpregnant women; ages and health conditions not stated | 480 mg | — | — |
| Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis 2016 · 930 mg/d choline group · pregnant, lactating, and nonpregnant women; ages and health conditions not stated | 930 mg | — | — |
| Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial 2021 · choline tablets · Healthy men and women aged 18 years or older with normal renal function | 1 g | 4 weeks | — |
| Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial 2021 · choline tablets with whole eggs · Healthy men and women aged 18 years or older with normal renal function | 1 g | 4 weeks | — |
| Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial 2021 · choline tablets with egg whites · Healthy men and women aged 18 years or older with normal renal function | 1 g | 4 weeks | — |
| Genetic Variants in One-Carbon Metabolism and Their Effects on DHA Biomarkers in Pregnant Women: A Post-Hoc Analysis 2022 · intervention group · Healthy pregnant women aged 21–40 years, BMI <32, enrolled at 12–16 gestational weeks | 550 mg | — | 15 |
| Differential metabolism of choline supplements in adult volunteers 2022 · Choline bitartrate · Healthy adult men aged 18 years or older | 1.34 g | 1 day | 6 |
| Choline Intake as Supplement or as a Component of Eggs Increases Plasma Choline and Reduces Interleukin-6 without Modifying Plasma Cholesterol in Participants with Metabolic Syndrome 2020 · choline supplements (choline bitartrate, CB) · Men and women aged 35–70 years with metabolic syndrome | 400 mg | 4 weeks | — |
| Intake of 3 Eggs per Day When Compared to a Choline Bitartrate Supplement, Downregulates Cholesterol Synthesis without Changing the LDL/HDL Ratio 2018 · CHOLINE · Healthy men and women aged 18–30 years | 398 mg | 4 weeks | 29 |
| Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load 2005 · Choline repletion diet: 275 mg level · Men aged 20–46 years who had developed clinical choline depletion | 275 mg | 10 days | 4 |
| Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load 2005 · Choline repletion diet: 413 mg level · Men aged 20–46 years who had developed clinical choline depletion | 413 mg | 10 days | 4 |
| Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men 2010 · 300 mg/d group · Men aged 18–55 years with folate-compromised status | 300 mg | 12 weeks | — |
| Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men 2010 · 2200 mg/d group · Men aged 18–55 years with folate-compromised status | 2.2 g | 12 weeks | — |
| Choline supplementation for preterm infants: metabolism of four Deuterium-labeled choline compounds 2023 · D9-choline chloride · Preterm infants born at 28 0/7–32 0/7 weeks’ gestation, both sexes, receiving enteral feeds | 2.7 mg/kg | 1 day | 8 |
| Choline supplementation for preterm infants: metabolism of four Deuterium-labeled choline compounds 2023 · D9-phosphoryl-choline · Preterm infants born at 28 0/7–32 0/7 weeks’ gestation, both sexes, receiving enteral feeds | 2.7 mg/kg | 1 day | 8 |
| Choline supplementation for preterm infants: metabolism of four Deuterium-labeled choline compounds 2023 · D9-GPC · Preterm infants born at 28 0/7–32 0/7 weeks’ gestation, both sexes, receiving enteral feeds | 2.7 mg/kg | 1 day | 8 |
| Different choline supplement metabolism in adults using deuterium labelling 2023 · D9-choline chloride · Healthy adult men aged 26–65 | 3.6 mg/kg | 1 day | 6 |
| Different choline supplement metabolism in adults using deuterium labelling 2023 · D9-phosphorylcholine · Healthy adult men aged 26–65 | 6.4 mg/kg | 1 day | 6 |
| Different choline supplement metabolism in adults using deuterium labelling 2023 · D9-GPC · Healthy adult men aged 26–65 | 6.4 mg/kg | 1 day | 6 |
| Combined choline and DHA supplementation: a randomized controlled trial 2020 · choline supplementation · Preterm infants born before 32 weeks postmenstrual age | 30 mg/kg | 10 days | — |
| Reproductive state and choline intake influence enrichment of plasma lysophosphatidylcholine-DHA: a post hoc analysis of a controlled feeding trial 2019 · 930 mg choline per day group · Healthy non-pregnant, third-trimester pregnant, and lactating women; reproductive groups were included in the analysis | 550 mg | 12 weeks | — |
| Feasibility and Acceptability of Maternal Choline Supplementation in Heavy Drinking Pregnant Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2018 · choline supplementation group · Pregnant women aged 18 or older with heavy alcohol consumption, recruited in Cape Town, South Africa | 2.5 g | — | 35 |
| Choline deficiency increases lymphocyte apoptosis and DNA damage in humans 2006 · choline repletion · Healthy men and women with organ dysfunction during choline depletion | 138 mg | 40 days | 27 |
| Pregnancy induces transcriptional activation of the peripheral innate immune system and increases oxidative DNA damage among healthy third trimester pregnant women 2012 · Pregnant women, 480 mg/d choline intake · Healthy pregnant women aged 21 years or older, at 26–29 weeks’ gestation | 100 mg | 12 weeks | 13 |
| Pregnancy induces transcriptional activation of the peripheral innate immune system and increases oxidative DNA damage among healthy third trimester pregnant women 2012 · Nonpregnant women, 480 mg/d choline intake · Healthy nonpregnant women aged 21 years or older | 100 mg | 12 weeks | 10 |
| Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load 2005 · Choline depletion diet · Healthy men aged 20–46 years | 50 mg | 6 weeks | 8 |
| Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load 2005 · Choline repletion diet: 138 mg level · Men aged 20–46 years who had developed clinical choline depletion | 138 mg | 10 days | 4 |
| Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy 2003 · choline treatment group · Lithium-treated patients with DSM-IV rapid-cycling bipolar disorder; age and sex not specified | 50 mg/kg | 12 weeks | — |
| Choline metabolome response to prenatal choline supplementation across pregnancy: A randomized controlled trial 2021 · control group · Pregnant people aged 21–40 years, at gestational weeks 12–16 at enrollment, without the listed medical conditions or pregnancy complications | 25 mg | 24 weeks | 16 |
| Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trial 2022 · Control group · Pregnant participants aged 21–40 years, enrolled at 12–16 weeks’ gestation, without the specified health conditions or pregnancy complications | 25 mg | 169 days | 15 |
| Genetic Variants in One-Carbon Metabolism and Their Effects on DHA Biomarkers in Pregnant Women: A Post-Hoc Analysis 2022 · control group · Healthy pregnant women aged 21–40 years, BMI <32, enrolled at 12–16 gestational weeks | 25 mg | — | 15 |
| Combined choline and DHA supplementation: a randomized controlled trial 2020 · combined choline and DHA supplementation · Preterm infants born before 32 weeks postmenstrual age | 30 mg/kg | 10 days | — |
| Choline supplementation reduces urinary carnitine excretion in humans 1996 · Experiment 1: choline plus pantothenate · Free-living adults; age range and sex not reported | 13.5 mmol | — | — |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 400 mg | 24 weeks | 501 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 400 mg | 24 weeks | 201 |
| Assessment of vitamin A, vitamin B(2), vitamin B(12), vitamin K, folate, and choline status following 4 months of multinutrient supplementation in healthy vegans: a randomised, double-blind, placebo-controlled trial 2025 · INT (intervention group; standard and double omega-3 dosage subgroups) · Healthy adults aged 18 years or older who had followed a vegan diet for at least 1 year; no diagnosed vitamin or mineral deficiency | 300 mg | 120 days | 35 |
| Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans 2005 · Study 4 phosphatidylcholine group · Healthy men aged 50–71 years with plasma homocysteine below 26 μmol/L | 2.6 g | 2 weeks | 26 |
| Choline metabolome response to prenatal choline supplementation across pregnancy: A randomized controlled trial 2021 · choline intervention group · Pregnant people aged 21–40 years, at gestational weeks 12–16 at enrollment, without the listed medical conditions or pregnancy complications | 550 mg | 24 weeks | 17 |
| Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trial 2022 · Intervention group · Pregnant participants aged 21–40 years, enrolled at 12–16 weeks’ gestation, without the specified health conditions or pregnancy complications | 550 mg | 171 days | 15 |
| Choline intake influences phosphatidylcholine DHA enrichment in nonpregnant women but not in pregnant women in the third trimester 2013 · Pregnant women, 480 mg choline/day · Pregnant women in the third trimester | 480 mg | 12 weeks | — |
| Choline intake influences phosphatidylcholine DHA enrichment in nonpregnant women but not in pregnant women in the third trimester 2013 · Pregnant women, 930 mg choline/day · Pregnant women in the third trimester | 930 mg | 12 weeks | — |
| Choline intake influences phosphatidylcholine DHA enrichment in nonpregnant women but not in pregnant women in the third trimester 2013 · Nonpregnant women, 480 mg choline/day · Nonpregnant women | 480 mg | 12 weeks | — |
| Choline intake influences phosphatidylcholine DHA enrichment in nonpregnant women but not in pregnant women in the third trimester 2013 · Nonpregnant women, 930 mg choline/day · Nonpregnant women | 930 mg | 12 weeks | — |
| Use of a Micronutrient Cocktail to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Adults with Obesity: A Randomized, Double-Blinded Pilot Clinical Trial 2024 · intervention group · Adults aged 18–70 with obesity and dyslipidemia | 500 mg | 90 days | 105 |
| The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial 2017 · Test product (Souvenaid/Fortasyn Connect) · Adults aged 50 years or older with mild probable or possible Alzheimer’s disease | 400 mg | 4 weeks | 16 |
| Reproductive state and choline intake influence enrichment of plasma lysophosphatidylcholine-DHA: a post hoc analysis of a controlled feeding trial 2019 · 480 mg choline per day group · Healthy non-pregnant, third-trimester pregnant, and lactating women; reproductive groups were included in the analysis | 100 mg | 12 weeks | — |
| Choline intakes exceeding recommendations during human lactation improve breast milk choline content by increasing PEMT pathway metabolites 2015 · 480 mg choline/day · Women; lactating and control women were enrolled, but arm-specific population details are not reported. | 480 mg | 11 weeks | — |